The present invention relates to tricyclic compounds of formula (I):
##STR1##
or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically
acceptable salt forms thereof, which are useful as inhibitors of HIV
reverse transcriptase, and to pharmaceutical compositions and diagnostic
kits comprising the same, and methods of using the same for treating viral
infection or as an assay standard or reagent.
